Pharmacosmos and G1 Therapeutics announced that Pharmacosmos has completed the previously announced tender offer to acquire all outstanding shares of G1 Therapeutics for $7.15 per share net to the holder in cash, without interest and less any applicable withholding taxes, for a total equity value of approximately $405 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTHX:
- Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period
- G1 Therapeutics, Pharmacosmos announce expiration of HSR waiting period
- Largest borrow rate increases among liquid names
- Biotech Alert: Searches spiking for these stocks today
- G1 Therapeutics reports Q2 EPS (10c), consensus (16c)